Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05919563
LTFU Study of Subjects Who Received GRNOPC1
Sponsor: Lineage Cell Therapeutics, Inc.
View on ClinicalTrials.gov
Summary
This is a LTFU study for thoracic SCI subjects that were administered GRNOPC1 cells in the main study CP35A007.
Official title: Long Term Follow-up of Subjects Who Received GRNOPC1
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
5
Start Date
2011-10-06
Completion Date
2026-12-12
Last Updated
2024-08-21
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
Magnetic Resonance Imaging (MRI)
Observational study; annual MRI for first 5 years only to monitor changes in the injection site
Locations (3)
Stanford University
Palo Alto, California, United States
Shepherd Center
Atlanta, Georgia, United States
Northwestern Medical Group
Evanston, Illinois, United States